Scinus Cell Expansion develops technologies and services that advance cell therapy and regenerative medicine. Our mission is to help make cell therapies accessible to patients worldwide. We are commercializing Osilaris™, a closed, GMP-compliant bioreactor system for stem cell cultivation. Osilaris™ provides a cost-effective, controlled alternative to conventional production, enabling expansion of adherent cells, suspension cells, and organoids within a single closed system. The system’s patented, single-use, volume-expandable culture bags allow large-scale expansion in a homogenized, low-shear environment—ideal for scaling out (stem) cell cultures. In addition, Scinus supports clients in translating cell culture processes into commercial-scale, GMP-compliant production strategies.
For more information, please visit our website (www.scinus.com).